Vivo Capital, LLC - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 81 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2022. The put-call ratio across all filers is 1.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
Vivo Capital, LLC ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$42,193,208
-33.1%
4,096,428
+7.0%
4.62%
+6.1%
Q2 2023$63,111,429
+83.2%
3,829,577
+1.8%
4.36%
+82.2%
Q1 2023$34,454,772
+174628.8%
3,761,438
+36.6%
2.39%
+5.3%
Q4 2022$19,719
-99.9%
2,754,095
-6.2%
2.27%
+39.7%
Q3 2022$14,715,000
+105.3%
2,937,0930.0%1.62%
+125.7%
Q2 2022$7,167,000
-64.3%
2,937,0930.0%0.72%
-47.9%
Q1 2022$20,060,000
-15.5%
2,937,0930.0%1.38%
-3.5%
Q4 2021$23,732,000
-17.6%
2,937,0930.0%1.43%
+10.8%
Q3 2021$28,784,000
+45.6%
2,937,0930.0%1.29%
+50.9%
Q2 2021$19,767,000
-25.6%
2,937,0930.0%0.86%
-8.3%
Q1 2021$26,551,000
+12.7%
2,937,093
-16.7%
0.93%
-11.2%
Q4 2020$23,554,000
+32.5%
3,526,0930.0%1.05%
+2.3%
Q3 2020$17,772,000
-37.6%
3,526,0930.0%1.03%
-49.7%
Q2 2020$28,491,000
+0.4%
3,526,093
-1.4%
2.04%
-20.6%
Q1 2020$28,389,0003,575,4242.57%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q3 2022
NameSharesValueWeighting ↓
WEALTH EFFECTS LLC 2,305,017$18,625,0007.73%
COWEN AND COMPANY, LLC 3,732,778$30,161,0002.74%
GENDELL JEFFREY L 2,446,299$19,766,0001.60%
Asymmetry Capital Management, L.P. 369,134$2,983,0001.58%
Vivo Capital, LLC 2,937,093$23,732,0001.43%
Samsara BioCapital, LLC 659,409$5,328,0001.03%
Altium Capital Management LP 440,589$3,560,0000.98%
Knott David M Jr 258,198$2,086,0000.71%
RTW INVESTMENTS, LP 5,741,939$46,395,0000.68%
FRAZIER MANAGEMENT LLC 951,814$7,691,0000.59%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders